You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

List of Excipients in API FROVATRIPTAN SUCCINATE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing FROVATRIPTAN SUCCINATE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Par Pharmaceutical FROVATRIPTAN SUCCINATE frovatriptan succinate 0603-3718 CELLULOSE, MICROCRYSTALLINE
Par Pharmaceutical FROVATRIPTAN SUCCINATE frovatriptan succinate 0603-3718 HYPROMELLOSES
Par Pharmaceutical FROVATRIPTAN SUCCINATE frovatriptan succinate 0603-3718 LACTOSE
Par Pharmaceutical FROVATRIPTAN SUCCINATE frovatriptan succinate 0603-3718 MAGNESIUM STEARATE
Par Pharmaceutical FROVATRIPTAN SUCCINATE frovatriptan succinate 0603-3718 POLYETHYLENE GLYCOL 3000
Par Pharmaceutical FROVATRIPTAN SUCCINATE frovatriptan succinate 0603-3718 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing FROVATRIPTAN SUCCINATE

Company Ingredient NDC Excipient
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299 ANHYDROUS LACTOSE
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299 HYPROMELLOSE 2910
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299 MAGNESIUM STEARATE
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299 MICROCRYSTALLINE CELLULOSE 102
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299 POLYETHYLENE GLYCOL 8000
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for FROVATRIPTAN SUCCINATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

FROVATRIPTAN SUCCINATE drug variants containing MAGNESIUM STEARATE

Company Ingredient NDC
Par Pharmaceutical frovatriptan succinate 0603-3718
STAT RX USA LLC frovatriptan succinate 16590-396
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299
Endo Pharmaceuticals Inc frovatriptan succinate 63481-025
Glenmark Pharmaceuticals Inc USA frovatriptan succinate 68462-694
Amneal Pharmaceuticals NY LLC frovatriptan succinate 69238-1539
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: SILICON DIOXIDE

FROVATRIPTAN SUCCINATE drug variants containing SILICON DIOXIDE

Company Ingredient NDC
Par Pharmaceutical frovatriptan succinate 0603-3718
STAT RX USA LLC frovatriptan succinate 16590-396
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299
Endo Pharmaceuticals Inc frovatriptan succinate 63481-025
Glenmark Pharmaceuticals Inc USA frovatriptan succinate 68462-694
Amneal Pharmaceuticals NY LLC frovatriptan succinate 69238-1539
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

FROVATRIPTAN SUCCINATE drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
Par Pharmaceutical frovatriptan succinate 0603-3718
STAT RX USA LLC frovatriptan succinate 16590-396
Ingenus Pharmaceuticals LLC frovatriptan succinate 50742-299
Endo Pharmaceuticals Inc frovatriptan succinate 63481-025
Glenmark Pharmaceuticals Inc USA frovatriptan succinate 68462-694
Amneal Pharmaceuticals NY LLC frovatriptan succinate 69238-1539
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group